Armistice Capital »

Nervgen Pharma Ord shares owned by Armistice Capital

Quarter-by-quarter ownership of Nervgen Pharma Ord (NGEN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Nervgen Pharma Ord

Tip: Access up to 7 years of quarterly data

All positions including Nervgen Pharma Ord held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nervgen Pharma Ord by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.4M 678k 2.06

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Nervgen Pharma Ord

Empery Asset Management
Rock Springs Capital Management
DAFNA Capital Management
Ghisallo Capital Management
Armistice Capital
LMR Partners
Stonepine Capital Management
Marshall Wace
UBS Group
Jane Street
Woodline Partners
PFG Investments
Susquehanna International
Bank of America Corporation
Royal Bank of Canada

View all funds holding Nervgen Pharma Ord